Cargando…

Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled

INTRODUCTION: The prevalence rate and related factors of insomnia remained unknown after the COVID-19 epidemic had been under control. Therefore, we conducted this survey to investigate the prevalence rate and related factors of insomnia symptoms in the Chinese general public after the COVID-19 had...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Junlong, Yang, Lulu, Xu, Yan, Zhang, Chenxi, Luo, Xian, Liu, Shuai, Yao, Lihua, Bai, Hanping, Zong, Xiaofen, Zhang, Jihui, Liu, Zhongchun, Zhang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180302/
https://www.ncbi.nlm.nih.gov/pubmed/34104023
http://dx.doi.org/10.2147/NSS.S307996
_version_ 1783703973275893760
author Guo, Junlong
Yang, Lulu
Xu, Yan
Zhang, Chenxi
Luo, Xian
Liu, Shuai
Yao, Lihua
Bai, Hanping
Zong, Xiaofen
Zhang, Jihui
Liu, Zhongchun
Zhang, Bin
author_facet Guo, Junlong
Yang, Lulu
Xu, Yan
Zhang, Chenxi
Luo, Xian
Liu, Shuai
Yao, Lihua
Bai, Hanping
Zong, Xiaofen
Zhang, Jihui
Liu, Zhongchun
Zhang, Bin
author_sort Guo, Junlong
collection PubMed
description INTRODUCTION: The prevalence rate and related factors of insomnia remained unknown after the COVID-19 epidemic had been under control. Therefore, we conducted this survey to investigate the prevalence rate and related factors of insomnia symptoms in the Chinese general public after the COVID-19 had been initially control. METHODS: An online survey was conducted among Chinese citizens through the JD Health APP. The questionnaire was used for collecting demographic data and self-designed questions related to the COVID-19 outbreak. Insomnia Severity Index, Patient Health Questionnaire-9, Somatic Symptom Scale-8 and Impact of Events Scale-Revised were used for measuring psychological symptoms. To examine the associations of sociodemographic and psychological factors with insomnia symptoms, a binary logistic regression was used. RESULTS: In total, there were 14,894 eligible participants, and 4601 (30.9%) participants were found to have insomnia symptoms. The regression model revealed that a higher risk of insomnia symptoms was associated with being over the age of 40 years, having history of psychiatric disorders, smoking, having infected friends or colleagues, having depressive or somatic symptoms, experiencing psychological distress and feeling estranged from family members. Meanwhile a lower risk of insomnia symptoms was associated with being female, having closer family relationships, not feeling alienated from others and being satisfied with the available information. CONCLUSION: In our study, 30.9% of the participants in the general public reported insomnia symptoms after the COVID-19 epidemic had been initially controlled. When providing precise interventions for insomnia, extra attention should be paid to the individuals who are male, elderly and smokers, and those with psychiatric disorder history, with infected friends or colleagues, with psychological symptoms and with poor social support.
format Online
Article
Text
id pubmed-8180302
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81803022021-06-07 Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled Guo, Junlong Yang, Lulu Xu, Yan Zhang, Chenxi Luo, Xian Liu, Shuai Yao, Lihua Bai, Hanping Zong, Xiaofen Zhang, Jihui Liu, Zhongchun Zhang, Bin Nat Sci Sleep Original Research INTRODUCTION: The prevalence rate and related factors of insomnia remained unknown after the COVID-19 epidemic had been under control. Therefore, we conducted this survey to investigate the prevalence rate and related factors of insomnia symptoms in the Chinese general public after the COVID-19 had been initially control. METHODS: An online survey was conducted among Chinese citizens through the JD Health APP. The questionnaire was used for collecting demographic data and self-designed questions related to the COVID-19 outbreak. Insomnia Severity Index, Patient Health Questionnaire-9, Somatic Symptom Scale-8 and Impact of Events Scale-Revised were used for measuring psychological symptoms. To examine the associations of sociodemographic and psychological factors with insomnia symptoms, a binary logistic regression was used. RESULTS: In total, there were 14,894 eligible participants, and 4601 (30.9%) participants were found to have insomnia symptoms. The regression model revealed that a higher risk of insomnia symptoms was associated with being over the age of 40 years, having history of psychiatric disorders, smoking, having infected friends or colleagues, having depressive or somatic symptoms, experiencing psychological distress and feeling estranged from family members. Meanwhile a lower risk of insomnia symptoms was associated with being female, having closer family relationships, not feeling alienated from others and being satisfied with the available information. CONCLUSION: In our study, 30.9% of the participants in the general public reported insomnia symptoms after the COVID-19 epidemic had been initially controlled. When providing precise interventions for insomnia, extra attention should be paid to the individuals who are male, elderly and smokers, and those with psychiatric disorder history, with infected friends or colleagues, with psychological symptoms and with poor social support. Dove 2021-06-01 /pmc/articles/PMC8180302/ /pubmed/34104023 http://dx.doi.org/10.2147/NSS.S307996 Text en © 2021 Guo et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Guo, Junlong
Yang, Lulu
Xu, Yan
Zhang, Chenxi
Luo, Xian
Liu, Shuai
Yao, Lihua
Bai, Hanping
Zong, Xiaofen
Zhang, Jihui
Liu, Zhongchun
Zhang, Bin
Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled
title Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled
title_full Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled
title_fullStr Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled
title_full_unstemmed Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled
title_short Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled
title_sort prevalence and risk factors associated with insomnia symptoms among the chinese general public after the coronavirus disease 2019 epidemic was initially controlled
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180302/
https://www.ncbi.nlm.nih.gov/pubmed/34104023
http://dx.doi.org/10.2147/NSS.S307996
work_keys_str_mv AT guojunlong prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled
AT yanglulu prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled
AT xuyan prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled
AT zhangchenxi prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled
AT luoxian prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled
AT liushuai prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled
AT yaolihua prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled
AT baihanping prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled
AT zongxiaofen prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled
AT zhangjihui prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled
AT liuzhongchun prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled
AT zhangbin prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled